Literature DB >> 8501205

Detection of polymerase chain reaction-amplified human immunodeficiency virus type 1 proviral DNA with a digoxigenin-labeled RNA probe and an enzyme-linked immunoassay.

Y He1, F Coutlée, P Saint-Antoine, C Olivier, H Voyer, A Kessous-Elbaz.   

Abstract

An enzyme-linked immunoassay (EIA) combined with a solution hybridization (SH) reaction was devised to detect human immunodeficiency virus type 1 (HIV-1) provirus amplified by the polymerase chain reaction (PCR). In this nonisotopic PCR assay, designated PCR-EIASH, a fragment of the HIV-1 gag gene from peripheral blood mononuclear cells (PBMCs) was first amplified with biotinylated primers. The biotinylated amplified DNA segment was reacted in solution with an internal RNA probe labeled with digoxigenin-11-UTP. Hybrids were captured in a microtiter plate coated with streptavidin. Specific bound hybrids were quantitated by the addition of an enzyme-labeled antibody against digoxigenin and a fluorogenic substrate. The hybridization, immunological, and amplification parameters of PCR-EIASH were optimized as follows: 12.5 pmol of each primer was used in the PCR; the reannealing reaction of amplified products with the RNA probe, which was used at 0.30 microgram/ml, was completed in 30 min at 70 degrees C in 2x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate). Five copies of HIV-1 DNA diluted in a lysate of 100,000 PBMCs from a seronegative control could be detected by PCR-EIASH with a signal of 41 +/- 3 fluorescent units above a background noise of 13 +/- 2 fluorescent units. A total of 91 PBMC lysates from 91 seropositive patients sampled once and 20 PBMC lysates from 10 seropositive patients sampled twice were tested in duplicate in the PCR-EIASH; 107 samples were positive in duplicate tests, 1 sample was indeterminate, and 3 samples were negative. Of the latter three samples, one became positive by diluting the cell lysate, suggesting the presence of an inhibitor of Taq polymerase. The three samples negative for HIV-1 by PCR-EIASH were also negative when amplified with SK145-SK39 and detected with 32P-labeled SK102.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501205      PMCID: PMC262877          DOI: 10.1128/jcm.31.5.1040-1047.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction amplification and capture hybridization in microtiter wells.

Authors:  G H Keller; D P Huang; M M Manak
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Rapid and quantitative detection of enzymatically amplified HIV-1 DNA using chemiluminescent oligonucleotide probes.

Authors:  C Y Ou; S H McDonough; D Cabanas; T B Ryder; M Harper; J Moore; G Schochetman
Journal:  AIDS Res Hum Retroviruses       Date:  1990-11       Impact factor: 2.205

3.  Non-radioactive labeling and detection of nucleic acids. I. A novel DNA labeling and detection system based on digoxigenin: anti-digoxigenin ELISA principle (digoxigenin system).

Authors:  C Kessler; H J Höltke; R Seibl; J Burg; K Mühlegger
Journal:  Biol Chem Hoppe Seyler       Date:  1990-10

4.  Discordance between primer pairs in the polymerase chain reaction for detection of human immunodeficiency virus type 1: a role for taq polymerase inhibitors.

Authors:  F Coutlée; P Saint-Antoine; C Olivier; A Vessous-Elbaz; H Voyer; F Berrada; P Bégin; L Giroux; R Viscidi
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

5.  Detection of human immunodeficiency virus type 1 by using the polymerase chain reaction and a time-resolved fluorescence-based hybridization assay.

Authors:  P O Dahlén; A J Iitiä; G Skagius; A Frostell; M F Nunn; M Kwiatkowski
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

Review 6.  The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis.

Authors:  B I Eisenstein
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

7.  Non-radioactive labeling of RNA transcripts in vitro with the hapten digoxigenin (DIG); hybridization and ELISA-based detection.

Authors:  H J Höltke; C Kessler
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

8.  Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction.

Authors:  M Holodniy; D A Katzenstein; S Sengupta; A M Wang; C Casipit; D H Schwartz; M Konrad; E Groves; T C Merigan
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

9.  Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals.

Authors:  J B Jackson; S Y Kwok; J J Sninsky; J S Hopsicker; K J Sannerud; F S Rhame; K Henry; M Simpson; H H Balfour
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

10.  Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA.

Authors:  F Coutlée; P Saint-Antoine; C Olivier; H Voyer; A Kessous-Elbaz; F Berrada; P Bégin; L Giroux; R Viscidi
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

View more
  3 in total

1.  Enzyme-linked immunoassay for detection of PCR-amplified DNA of legionellae in bronchoalveolar fluid.

Authors:  D Jonas; A Rosenbaum; S Weyrich; S Bhakdi
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

2.  Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay.

Authors:  F Coutlée; D Provencher; H Voyer
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

3.  Low human immunodeficiency virus type 1 (HIV-1) DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR.

Authors:  M Zazzi; L Romano; M Catucci; A De Milito; P Almi; A Gonnelli; M Rubino; P E Valensin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.